Cargando…

Correlation of HIV-1 drug resistant mutations and virologic failure

INTRODUCTION: mutations are important by ensuring that the HIV-1 agent remains fit in the environment and evades drugs that are developed purposely to kill them. In Kenya, mutations conferring resistance to available ARVs have been reported in previous studies. However, there is a paucity of informa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Makwaga, Olipher, Mulama, David Hughes, Muoma, John, Mwau, Matilu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The African Field Epidemiology Network 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8449576/ https://www.ncbi.nlm.nih.gov/pubmed/34584606 http://dx.doi.org/10.11604/pamj.2021.39.180.28818

Ejemplares similares

Prevalence of human immunodeficiency virus-1 drug-resistant mutations among adults on first- and second-line antiretroviral therapy in a resource-limited health facility in Busia County, Kenya
por: Makwaga, Olipher, et al.
Publicado: (2020)

Human immunodeficiency virus (HIV) type 1 genetic diversity in HIV positive individuals on antiretroviral therapy in a cross-sectional study conducted in Teso, Western Kenya
por: Adhiambo, Maureen, et al.
Publicado: (2021)

Tsetse distribution, trypanosome infection rates, and small-holder livestock producers’ capacity enhancement for sustainable tsetse and trypanosomiasis control in Busia, Kenya
por: Adungo, Ferdinard, et al.
Publicado: (2020)

Burden of hypertension and associated factors among HIV-positive adults in Busia County, Kenya
por: Oyawa, Ibrahim, et al.
Publicado: (2022)

Prevalence and factors associated with HIV-1 drug resistance mutations in treatment-experienced patients in Nairobi, Kenya: A cross-sectional study
por: Scriven, Yvonne A., et al.
Publicado: (2021)

Evaluation of Clinical and Immunological Markers for Predicting Virological Failure in a HIV/AIDS Treatment Cohort in Busia, Kenya
por: Ferreyra, Cecilia, et al.
Publicado: (2012)

Performance and usability evaluation of the INSTI HIV self-test in Kenya for qualitative detection of antibodies to HIV
por: Bwana, Priska, et al.
Publicado: (2018)

Performance and usability of Cepheid GeneXpert HIV-1 qualitative and quantitative assay in Kenya
por: Bwana, Priska, et al.
Publicado: (2019)

Patterns of acquired HIV-1 drug resistance mutations and predictors of virological failure in Moshi, Northern Tanzania
por: Mziray, Shabani Ramadhani, et al.
Publicado: (2020)

Pretreatment HIV drug resistance results in virological failure and accumulation of additional resistance mutations in Ugandan children
por: Kityo, Cissy, et al.
Publicado: (2017)

Drug resistance in HIV patients with virological failure or slow virological response to antiretroviral therapy in Ethiopia
por: Abdissa, Alemseged, et al.
Publicado: (2014)

Antiretroviral Genotypic Resistance Mutations in HIV-1 Infected Korean Patients with Virologic Failure
por: Chin, Bum Sik, et al.
Publicado: (2009)

HIV-1 Drug Resistance, Distribution of Subtypes, and Drug Resistance-Associated Mutations in Virologic Failure Individuals in Chengdu, Southwest China, 2014-2016
por: Chen, Jiayi, et al.
Publicado: (2020)

Kaposi’s sarcoma-associated herpesvirus protein ORF75 among HIV-1 patients in Kenya
por: Demba, Rodgers N., et al.
Publicado: (2020)

Early virological failure and HIV drug resistance in Ugandan adults co-infected with tuberculosis
por: von Braun, Amrei, et al.
Publicado: (2017)

Current ART, determinants for virologic failure and implications for HIV drug resistance: an umbrella review
por: SeyedAlinaghi, SeyedAhmad, et al.
Publicado: (2023)

Hepatitis B, Hepatitis C and HIV-1 Coinfection in Two Informal Urban Settlements in Nairobi, Kenya
por: Kerubo, Glennah, et al.
Publicado: (2015)

HIV Drug Resistance Mutations (DRMs) Detected by Deep Sequencing in Virologic Failure Subjects on Therapy from Hunan Province, China
por: Chen, Xi, et al.
Publicado: (2016)

Correction: Hepatitis B, Hepatitis C and HIV-1 Coinfection in Two Informal Urban Settlements in Nairobi, Kenya
por: Kerubo, Glennah, et al.
Publicado: (2015)

Secondary bacterial infections and antibiotic resistance among tungiasis patients in Western, Kenya
por: Nyangacha, Ruth Monyenye, et al.
Publicado: (2017)

HIV multi-drug resistance at first-line antiretroviral failure and subsequent virological response in Asia
por: Jiamsakul, Awachana, et al.
Publicado: (2014)

Prevalence and patterns of HIV drug resistance in patients with suspected virological failure in North-Western Tanzania
por: Henerico, Shimba, et al.
Publicado: (2021)

HIV-1 genotypic drug resistance in patients with virological failure to single-tablet antiretroviral regimens in southern Taiwan
por: Tsai, Hung-Chin, et al.
Publicado: (2018)

HIV virological failure and drug resistance among injecting drug users receiving first-line ART in China
por: Leng, Xuebing, et al.
Publicado: (2014)

Virological Failure and HIV-1 Drug Resistance Mutations among Naive and Antiretroviral Pre-Treated Patients Entering the ESTHER Program of Calmette Hospital in Cambodia
por: Barennes, Hubert, et al.
Publicado: (2014)

Clinical impact of ultra deep versus Sanger sequencing detection of minority mutations on HIV-1 drug resistance genotype interpretation after virological failure
por: Mohamed, Sofiane, et al.
Publicado: (2014)

Experience from a pilot point-of-care CD4 enumeration programme in Kenya
por: Mwau, Matilu, et al.
Publicado: (2016)

Pre-treatment minority HIV-1 drug resistance mutations and long term virological outcomes: is prediction possible?
por: Mzingwane, M. L., et al.
Publicado: (2016)

An in vitro evaluation of drugs used in the Kenyan ART program
por: Muriuki, Joseph, et al.
Publicado: (2016)

HIV virologic response, patterns of drug resistance mutations and correlates among adolescents and young adults: A cross-sectional study in Tanzania
por: Rugemalila, Joan, et al.
Publicado: (2023)

Prevalence of HIV Antiretroviral Drug Resistance and Its Impacts on HIV-1 Virological Failures in Jiangsu, China: A Cross-Sectional Study
por: Zhou, Ying, et al.
Publicado: (2016)

Rate of virological failure and HIV-1 drug resistance among HIV-infected adolescents in routine follow-up on health facilities in Cameroon
por: Penda, Calixte Ida, et al.
Publicado: (2022)

Impact of pretreatment low-abundance HIV-1 drug-resistant variants on virological failure among HIV-1/TB-co-infected individuals
por: Chimukangara, Benjamin, et al.
Publicado: (2020)

Virological failure, HIV-1 drug resistance, and early mortality in adults admitted to hospital in Malawi: an observational cohort study
por: Gupta-Wright, Ankur, et al.
Publicado: (2020)

Prospective evaluation of accuracy of HIV viral load monitoring using the Aptima HIV Quant Dx assay with fingerstick and venous dried blood spots prepared under field conditions in Kenya
por: Mwau, Matilu, et al.
Publicado: (2021)

Survival among antiretroviral-experienced HIV-2 patients experiencing virologic failure with drug resistance mutations in Cote d’Ivoire West Africa
por: Tchounga, Boris K., et al.
Publicado: (2020)

Nevirapine plasma concentration is associated with virologic failure and the emergence of drug-resistant mutations among HIV patients in Kenya: A cross sectional study
por: Omondi, Evans Okumu, et al.
Publicado: (2022)

Virologic suppression in response to antiretroviral therapy despite extensive resistance within HIV-1 reverse transcriptase after the first virologic failure
por: Oliveira, Marta Iglis, et al.
Publicado: (2018)

Predictors of virologic outcome among people living with HIV who continue a protease inhibitor-based antiretroviral regimen following virologic failure with no or limited resistance
por: Salata, Robert A., et al.
Publicado: (2023)

Relating protease inhibitor resistance at time of virological failure with drug exposure
por: Van Luin, M, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_j1b7g7pbk35ol1fqkopipsgf20